Neuropace, Inc. NPCE Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s share based compensation arrangement by share based payment award options exercisable number.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s share based compensation arrangement by share based payment award options exercisable number?
- Neuropace, Inc. (NPCE) reported share based compensation arrangement by share based payment award options exercisable number of $1.89M in Q1 2026.
- How has Neuropace, Inc.'s share based compensation arrangement by share based payment award options exercisable number changed year-over-year?
- Neuropace, Inc.'s share based compensation arrangement by share based payment award options exercisable number increased by 17.5% year-over-year, from $1.61M to $1.89M.
- What is the long-term trend for Neuropace, Inc.'s share based compensation arrangement by share based payment award options exercisable number?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s share based compensation arrangement by share based payment award options exercisable number has grown at a 14.7% compound annual growth rate (CAGR), from $1.03M to $1.79M.